MR-guided focus ultrasound (MRgFUS) for symptomatic uterine fibroids: predictors of treatment success
Authors:
Open Access
- 26 September 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 27 (12) , 3425-3431
Abstract
What are the factors associated with long-term success in patients with symptomatic uterine fibroids treated by magnetic resonance-guided focus ultrasound (MRgFUS) and can they be employed to create a clinically useful index that predicts long-term efficacy? Hypo-intense fibroids on T2-weighted magnetic resonance imaging (MRI) and older age were associated with higher success rates and can be used to predict success rates on the basis of their presence or absence as pre-treatment parameters. The signal intensity of baseline T2-weighted MRI images and non-perfused volume at the end of the treatment can be correlated with MRgFUS outcome. This was a retrospective analysis of 81 patients who were treated by MRgFUS for symptomatic uterine fibroids, in an academic affiliated center between 2003 and 2008. There was a post-treatment phone interview >6 months following MRgFUS for symptomatic uterine fibroids. The eighty-one patients completed a successful MRgFUS treatment during this period, of whom 74 were included in the final analysis (1 was post-menopausal at treatment and 5 were lost for follow-up). The mean time for the phone interview was 33.0 ± 15.1 months (range: 6–53 months) after the MRgFUS treatment. Fifty-five patients (69%) did not need any additional alternative treatment following MRgFUS. Nineteen patients (24%) underwent other surgical interventions. Hypo-intense fibroids were associated with a higher chance of success than hyper-intense fibroids [odds ratio = 2.96 (1.01–8.71); P = 0.04] for surgery in hyper-intense fibroids). Women with long-term treatment success were significantly older at the time of treatment [46.3 ± 3.8 (range: 37–53) years versus 43.6 ± 4.4 (range: 36–51) years, respectively; P = 0.02]. Retrospective non-comparative studies are suboptimal and might overemphasize favorable outcomes. This paper can contribute to selection of suitable candidates for the MRgFUS treatment for patients with uterine fibroids' and can serve as a guide for gynecologists for a better patient selection. None. N/A.Keywords
This publication has 22 references indexed in Scilit:
- Eligibility and accessibility of magnetic resonance–guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomasFertility and Sterility, 2010
- Clinical outcomes of magnetic resonance‐guided focused ultrasound surgery for uterine myomas: 24‐month follow‐upUltrasound in Obstetrics & Gynecology, 2009
- Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroidsInternational Journal of Technology Assessment in Health Care, 2009
- Uterine Leiomyomas: MR Imaging–guided Focused Ultrasound Surgery—Imaging Predictors of SuccessRadiology, 2008
- Subjective effect of magnetic resonance‐guided focused ultrasound surgery for uterine fibroidsJournal of Obstetrics and Gynaecology Research, 2007
- Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance‐guided focused ultrasound surgeryUltrasound in Obstetrics & Gynecology, 2007
- Sustained Relief of Leiomyoma Symptoms by Using Focused Ultrasound SurgeryObstetrics & Gynecology, 2007
- Taking the American Journal of Obstetrics & Gynecology into the 21st centuryAmerican Journal of Obstetrics and Gynecology, 2007
- Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroidsFertility and Sterility, 2006
- Predictive factors for fibroids recurrence after uterine artery embolisationBJOG: An International Journal of Obstetrics & Gynaecology, 2005